Top Markets
Coin of the day
Monterey Bio Acquisition Corporation Monterey Bio Acquisition Corporation

Monterey Bio Acquisition Corporation

MTRY
Rang in aandelen #19503
Monterey Bio Acquisition Corporation currently lacks substantial operational... Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combination—including but not limited to mergers, capital stock exchanges, asset acquisitions, or reorganizations—with companies in the biotechnology industry. The firm, established in 2020, was formerly known as Chardan FinTech Acquisition Corp. and rebranded to Monterey Bio Acquisition Corporation in April 2021. It is headquartered in New York, New York.
Aandeelprijs
$11.14
Laatst gesynchroniseerd: 2023-11-28
Marktkapitalisatie
$160.14M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Monterey Bio Acquisition Corporation (MTRY)
Dividendrendementgeschiedenis voor Monterey Bio Acquisition Corporation (MTRY)
Het dividendrendement (TTM) van Monterey Bio Acquisition Corporation (aandelsymbool: MTRY) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Monterey Bio Acquisition Corporation (MTRY) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten